← Back to Clinical Trials
Recruiting NCT06610552

NCT06610552 Powerly - Science-based Digital Intervention Preventing Postpartum Depression and Anxiety

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06610552
Status Recruiting
Phase
Sponsor Marta Marciniak
Condition Stress
Study Type INTERVENTIONAL
Enrollment 140 participants
Start Date 2024-02-01
Primary Completion 2026-10-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Powerly

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 140 participants in total. It began in 2024-02-01 with a primary completion date of 2026-10-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to determine if the Powerly app can help prevent postpartum depression and anxiety in healthy pregnant women. The main questions it aims to answer are: * Does the Powerly app reduce postpartum depression and anxiety? * Does it improve emotion regulation and maternal bonding with a child? Researchers will compare two groups: one using the Powerly app and the other receiving care as usual (CAU) to see if the app leads to better mental health outcomes. Participants will: * Use the Powerly app for four weeks (if in the intervention group). * Complete mental health assessments before the study, after four weeks, and six weeks postpartum.

Eligibility Criteria

Inclusion Criteria: * being between 24 and 32 weeks pregnant, * owning an iPhone, * having sufficient fluency in German language Exclusion Criteria: * high-risk pregnancies, * history of substance abuse and psychiatric disorders such as bipolar disorder, schizophrenia, or other psychotic disorders, * current use of professional face-to-face psychotherapeutic support, * participation in other clinical trials or interventions at the same time

Contact & Investigator

Central Contact

Marta A. Marciniak, PhD

✉ marciniak@essb.eur.nl

📞 0031-107545276

Frequently Asked Questions

Who can join the NCT06610552 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06610552 currently recruiting?

Yes, NCT06610552 is actively recruiting participants. Contact the research team at marciniak@essb.eur.nl for enrollment information.

Where is the NCT06610552 trial being conducted?

This trial is being conducted at Zurich, Switzerland.

Who is sponsoring the NCT06610552 clinical trial?

NCT06610552 is sponsored by Marta Marciniak. The trial plans to enroll 140 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology